Société Agios Pharmaceuticals, Inc.
Actions
AGIO
US00847X1046
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
32,5 USD | -0,79% | +2,17% | +45,94% |
16/02 | AGIOS PHARMACEUTICALS, INC. : Opinion positive de RBC Capital Markets | ZM |
15/02 | Agios Pharmaceuticals, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2023 | CI |
Métier
Nombre d'employés: 385
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Medicines for Cellular Metabolism
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +88,36% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 14 | 100,0 % | 27 | 100,0 % | +88,36% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 08/08/22 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 26/09/22 |
Jacqualyn Fouse
CHM | Chairman | 62 | 05/12/17 |
Sarah Gheuens
CTO | Chief Tech/Sci/R&D Officer | 45 | 01/12/19 |
Clive Patience
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/06/17 |
Investor Relations Contact | - | - | |
Charlie Newman
PRN | Corporate Officer/Principal | - | 01/01/22 |
Ellen Lopresti
HRO | Human Resources Officer | - | 01/01/17 |
T. Washburn
AUD | Comptroller/Controller/Auditor | 43 | - |
Tsveta Milanova
PRN | Corporate Officer/Principal | 47 | 03/01/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 01/06/23 |
Director/Board Member | 64 | 09/12/14 | |
May Kin Ho
BRD | Director/Board Member | 71 | 23/06/15 |
Jacqualyn Fouse
CHM | Chairman | 62 | 05/12/17 |
David Scadden
BRD | Director/Board Member | 71 | 27/05/17 |
Brian Goff
CEO | Chief Executive Officer | 55 | 08/08/22 |
Cynthia Smith
BRD | Director/Board Member | 55 | 11/08/22 |
Rahul Ballal
BRD | Director/Board Member | 46 | 11/08/22 |
Catherine Owen
BRD | Director/Board Member | - | 13/06/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 72 989 377 | 55 944 826 ( 76,65 %) | 16 216 411 ( 22,22 %) | 76,65 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+45,94% | 1,85 Md | |
-3,46% | 102 Md | |
+1,41% | 96,09 Md | |
+2,13% | 22,28 Md | |
-15,84% | 21,4 Md | |
-9,21% | 18,14 Md | |
-39,98% | 17,02 Md | |
-14,65% | 16,09 Md | |
+4,39% | 13,83 Md | |
+31,35% | 11,97 Md |
- Bourse
- Actions
- Action AGIO
- Société Agios Pharmaceuticals, Inc.